bioMerieux S.A. (BIM) - Medical Equipment - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy lEtoile, France.
bioMerieux S.A. (BIM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy lEtoile, France.
bioMerieux S.A. (BIM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux S.A., Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux S.A., Medical Equipment, Deals By Market, 2011 to YTD 2017 9
bioMerieux S.A., Medical Equipment, Deals Summary, 2011 to YTD 2017 10
bioMerieux S.A., Medical Equipment, Deal Details 12
Venture Financing 12
Quanterix Raises US$19 Million In Series C Financing 12
Private Equity 13
BioTheranostics Raises USD32 Million in Private Equity Financing 13
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 14
Partnerships 14
Quanterix Enters into Licensing Agreement with bioMerieux 14
BioMerieux Enters into Licensing Agreement with Astute Medical 15
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 16
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 17
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 17
Biomerieux Enters into Agreement with Banyan Biomarkers 18
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 19
Biotheranostics Enters into Agreement with Syapse 20
BioMerieux Enters into Co-Development Agreement with Copan Italia 20
BioMerieux Enters into Distribution Agreement with Copan 21
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 22
BioMerieux Enters into Co-Development Agreement with Illumina 22
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 23
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 24
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 25
Debt Offering 26
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 26
Acquisition 27
BioMerieux Acquires Applied Maths 27
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 28
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 29
bioMerieux Completes Acquisition Of AES Laboratoire 30
bioMerieux Acquires Argene 31
bioMerieux S.A. - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 41
Financial Announcements 41
Apr 20, 2017: bioMerieux First-Quarter 2017 Business Review 41
Jan 19, 2017: bioMerieux Fourth-Quarter 2016 Business Review 45
Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 47
Aug 31, 2016: bioMerieux - First-Half 2016 Results 49
Jul 18, 2016: bioMerieux Second-Quarter 2016 Business Review 53
Apr 20, 2016: bioMrieux First-Quarter 2016 Business Review 56
Mar 02, 2016: bioMerieux 2015 Financial Results 58
Jan 21, 2016: bioMerieux Fourth-Quarter 2015 Business Review 62
Corporate Communications 65
Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 65
Product News 66
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 66
Jul 06, 2016: bioMerieux enlarges its pathogen identification capability on VITEK MS 67
Other Significant Developments 68
Aug 08, 2016: ITL contract extended with bioMerieux 68
May 31, 2016: bioMerieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 69
Mar 22, 2016: bioMrieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories 70
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71
bioMerieux S.A., Medical Equipment, Key Facts, 2016 1
bioMerieux S.A., Medical Equipment, Deals Summary, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux S.A., Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux S.A., Deals By Market, 2011 to YTD 2017 9
bioMerieux S.A., Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Quanterix Raises US$19 Million In Series C Financing 12
BioTheranostics Raises USD32 Million in Private Equity Financing 13
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 14
Quanterix Enters into Licensing Agreement with bioMerieux 14
BioMerieux Enters into Licensing Agreement with Astute Medical 15
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 16
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 17
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 17
Biomerieux Enters into Agreement with Banyan Biomarkers 18
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 19
Biotheranostics Enters into Agreement with Syapse 20
BioMerieux Enters into Co-Development Agreement with Copan Italia 20
BioMerieux Enters into Distribution Agreement with Copan 21
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 22
BioMerieux Enters into Co-Development Agreement with Illumina 22
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 23
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 24
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 25
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 26
BioMerieux Acquires Applied Maths 27
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 28
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 29
bioMerieux Completes Acquisition Of AES Laboratoire 30
bioMerieux Acquires Argene 31
bioMerieux S.A., Key Competitors 33
bioMerieux S.A., Key Employees 34
bioMerieux S.A., Other Locations 36
bioMerieux S.A., Subsidiaries 36
bioMerieux S.A., Medical Equipment, Deals by Type, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Market, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux S.A., Medical Equipment, Deals by Type, 2011 to YTD 2017 7
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux S.A., Medical Equipment, Deals by Market, 2011 to YTD 2017 9
Table of Contents 2
List of Tables 4
List of Figures 5
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux S.A., Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux S.A., Medical Equipment, Deals By Market, 2011 to YTD 2017 9
bioMerieux S.A., Medical Equipment, Deals Summary, 2011 to YTD 2017 10
bioMerieux S.A., Medical Equipment, Deal Details 12
Venture Financing 12
Quanterix Raises US$19 Million In Series C Financing 12
Private Equity 13
BioTheranostics Raises USD32 Million in Private Equity Financing 13
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 14
Partnerships 14
Quanterix Enters into Licensing Agreement with bioMerieux 14
BioMerieux Enters into Licensing Agreement with Astute Medical 15
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 16
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 17
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 17
Biomerieux Enters into Agreement with Banyan Biomarkers 18
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 19
Biotheranostics Enters into Agreement with Syapse 20
BioMerieux Enters into Co-Development Agreement with Copan Italia 20
BioMerieux Enters into Distribution Agreement with Copan 21
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 22
BioMerieux Enters into Co-Development Agreement with Illumina 22
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 23
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 24
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 25
Debt Offering 26
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 26
Acquisition 27
BioMerieux Acquires Applied Maths 27
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 28
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 29
bioMerieux Completes Acquisition Of AES Laboratoire 30
bioMerieux Acquires Argene 31
bioMerieux S.A. - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 41
Financial Announcements 41
Apr 20, 2017: bioMerieux First-Quarter 2017 Business Review 41
Jan 19, 2017: bioMerieux Fourth-Quarter 2016 Business Review 45
Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 47
Aug 31, 2016: bioMerieux - First-Half 2016 Results 49
Jul 18, 2016: bioMerieux Second-Quarter 2016 Business Review 53
Apr 20, 2016: bioMrieux First-Quarter 2016 Business Review 56
Mar 02, 2016: bioMerieux 2015 Financial Results 58
Jan 21, 2016: bioMerieux Fourth-Quarter 2015 Business Review 62
Corporate Communications 65
Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 65
Product News 66
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 66
Jul 06, 2016: bioMerieux enlarges its pathogen identification capability on VITEK MS 67
Other Significant Developments 68
Aug 08, 2016: ITL contract extended with bioMerieux 68
May 31, 2016: bioMerieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 69
Mar 22, 2016: bioMrieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories 70
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71
List Of Tables
bioMerieux S.A., Medical Equipment, Key Facts, 2016 1
bioMerieux S.A., Medical Equipment, Deals Summary, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux S.A., Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux S.A., Deals By Market, 2011 to YTD 2017 9
bioMerieux S.A., Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Quanterix Raises US$19 Million In Series C Financing 12
BioTheranostics Raises USD32 Million in Private Equity Financing 13
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 14
Quanterix Enters into Licensing Agreement with bioMerieux 14
BioMerieux Enters into Licensing Agreement with Astute Medical 15
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 16
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 17
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 17
Biomerieux Enters into Agreement with Banyan Biomarkers 18
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 19
Biotheranostics Enters into Agreement with Syapse 20
BioMerieux Enters into Co-Development Agreement with Copan Italia 20
BioMerieux Enters into Distribution Agreement with Copan 21
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 22
BioMerieux Enters into Co-Development Agreement with Illumina 22
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 23
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 24
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 25
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 26
BioMerieux Acquires Applied Maths 27
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 28
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 29
bioMerieux Completes Acquisition Of AES Laboratoire 30
bioMerieux Acquires Argene 31
bioMerieux S.A., Key Competitors 33
bioMerieux S.A., Key Employees 34
bioMerieux S.A., Other Locations 36
bioMerieux S.A., Subsidiaries 36
List Of Figures
bioMerieux S.A., Medical Equipment, Deals by Type, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Market, 2011 to YTD 2017 1
bioMerieux S.A., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux S.A., Medical Equipment, Deals by Type, 2011 to YTD 2017 7
bioMerieux S.A., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux S.A., Medical Equipment, Deals by Market, 2011 to YTD 2017 9
RELATED REPORTS
bioMerieux SA (BIM) - Product Pipeline Analysis, 2020 Update
bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems,
View ReportMicrobiology Diagnostic Devices And Equipment Global Market Report 2020 Including: 1) By Type: Laboratory Instruments, Microbiology Analysers 2) By End User: Hospitals, Diagnostic centres, Customer Lab service providers, Academic institutes, Research institutes 3) By Laboratory Instruments: Incubators, Gram Stainers, Bacterial Colony Counters, Petri Dish Fillers, Automated Culture Systems 4) By Micro-Biology Analyzers: Microbiology Diagnostics Instruments, Microscopes 5) By Reagents: Pathogen-Specific Kits, General Reagents Covering: Becton, Dickinnson and Company, Biomerieux, Danaher, Thermo Fisher Scientific, Abbott Laboratories (US)
Microbiology Diagnostic Devices And Equipment Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
